|

TPG Capital has announced  that it has entered into a definitive agreement to acquire Quebec based Axcan Pharma Inc. in an all cash deal valued at US$1.3 billion. Davies is  counsel to TPG Capital. Axcan is currently traded on the Nasdaq and the Toronto Stock Exchange.

|

2007